The U.S. Drug Enforcement Administration has proposed reducing its manufacturing quota for opioid medications for the third year in a row, a move that some say is focusing on the wrong end of the equation when it comes to opioid overuse.
The DEA wants to cut back on production quotas for what it says are the six-most frequently misused opioids: oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine and fentanyl. The proposed quota reduction, which averages 10%, would follow average decreases of 35% in 2017 and 5% this year.
The quota is intended to prevent overproduction of opioids tha...
Comments